Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today.
Reported sales increased 6.8% year-over-year to $24 billion. Operational sales were up 5.4%.
GAAP net earnings rose 91% to $5.2 billion, or $2.12 per share, compared to last year. Adjusted EPS grew 16% to $2.80.
Revenue and earnings beat estimates.
The company raised its sales guidance for the full year of 2025 and now expects reported sales to be $93.5-93.9 billion. It reaffirmed its guidance for adjusted EPS, which is expected to be $10.80-10.90.
In a separate release, JNJ announced its intent to separate its Orthopaedics business to improve strategic focus and drive shareholder value. The transaction would create a standalone orthopaedics business named DePuy Synthes. The company has appointed Namal Nawana as Worldwide President, DePuy Synthes, effective immediately. It expects to complete this transaction within 18 to 24 months, based on certain conditions.
JNJ also declared a cash dividend of $1.30 per common share for the fourth quarter of 2025, payable on December 9, 2025 to shareholders of record as of November 25, 2025.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
